Timolol Maleate Ophthalmic Solution
Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
11,818 recalls · Class II, newest first
Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Presence of foreign substance: Product complaint of foreign material in reconstituted bottle.
Lack of Assurance of Sterility: Complaints of syringe breakage
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.
CGMP Deviations
CGMP Deviations
Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in the intact pouch.
Lack of assurance of sterility: bags have the potential to leak..
Subpotent Drug
cGMP Diviations
Failed Dissolution Specifications
Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.
Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
Failed Stability Specification: Water determination was found not complying with specification.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.
Failed Impurities/Degradation Specifications: Out-of-specification test results.
CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.
Failed Stability Specifications: Out of specification for blend uniformity.